Lessons learned from a phase III population pharmacokinetic study of cariporide in coronary artery bypass graft surgery

Clinical Pharmacology and Therapeutics

Volumn 71, Issue 6, 2002, Pages 457-467

  Weber, Willi ^a   Harnisch, Lutz ^a   Jessel, Andreas ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARIPORIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; HEART INFARCTION; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RISK ASSESSMENT;

AGED; ANTI-ARRHYTHMIA AGENTS; CORONARY ARTERY BYPASS; DEATH, SUDDEN, CARDIAC; DRUG ADMINISTRATION SCHEDULE; FEMALE; GUANIDINES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SULFONES;

EID: 0036296910     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2002.124078     Document Type: Article

References (18)

1. + exchange inhibitor and its effects in cardiac ischaemia
2. Potential of selective sodium-hydrogen exchange inhibitors in cardiovascular therapy
3. + exchange and its inhibition in cardiac ischemia and reperfusion
4. Kinetics of calcium accumulation in acute myocardial ischemic injury
5. Contracture and the calcium paradox in the rat heart
6. Cell-to-cell interaction: A mechanism to explain wave-front progression of myocardial necrosis
7. Morphologic changes of heart muscle caused by successive perfusion with calcium-free and calcium-containing solutions (calcium paradox)
8. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations: Main results of the GUARDIAN trial
9. Learning versus confirming in clinical drug development
10. Prediction of creatinine clearance from serum creatinine
11. Myocardial cell protection: A challenging time for action and challenging time for clinical research